Goldberg, M. S., J. J. Siegel, K. Ahmed, S. J. Kurley, and A. S. Farberg. “A Prospective Clinical Utility Study Demonstrates That Physicians Use the 40-Gene Expression Profile (40-GEP) to Guide Clinical Management Decisions for Medicare-Eligible Patients With Cutaneous Squamous Cell Carcinoma (cSCC)”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, p. s95, doi:10.25251/skin.6.supp.95.